Poordad F - Search Results

1

Tobacco and other factors have a negative impact on quality of life in hepatitis C patients.

Yamini D, Basseri B, Chee GM, Arakelyan A, Enayati P, Tran TT, Poordad F. Yamini D, et al. Among authors: poordad f. J Viral Hepat. 2011 Oct;18(10):714-20. doi: 10.1111/j.1365-2893.2010.01361.x. Epub 2010 Aug 15. J Viral Hepat. 2011. PMID: 20723039

2

Screening for hepatitis B in chemotherapy patients: survey of current oncology practices.

Tran TT, Rakoski MO, Martin P, Poordad F. Tran TT, et al. Among authors: poordad f. Aliment Pharmacol Ther. 2010 Jan 15;31(2):240-6. doi: 10.1111/j.1365-2036.2009.04158.x. Epub 2009 Oct 8. Aliment Pharmacol Ther. 2010. PMID: 19814747 Free article.

3

Developments in hepatitis C therapy during 2000-2002.

Poordad FF, Tran T, Martin P. Poordad FF, et al. Expert Opin Emerg Drugs. 2003 May;8(1):9-25. doi: 10.1517/14728214.8.1.9. Expert Opin Emerg Drugs. 2003. PMID: 14610908 Review.

4

Advances in liver transplantation. New strategies and current care expand access, enhance survival.

Tran TT, Nissen N, Poordad FF, Martin P. Tran TT, et al. Among authors: poordad ff. Postgrad Med. 2004 May;115(5):73-6, 79-85. doi: 10.3810/pgm.2004.05.1514. Postgrad Med. 2004. PMID: 15171080 Review.

5

Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent.

Firpi RJ, Tran TT, Flores P, Nissen N, Colquhoun S, Shackleton C, Martin P, Vierling JM, Poordad FF. Firpi RJ, et al. Among authors: poordad ff. Aliment Pharmacol Ther. 2004 May 1;19(9):1033-9. doi: 10.1111/j.1365-2036.2004.01923.x. Aliment Pharmacol Ther. 2004. PMID: 15113371 Free article. Review.

6

Cost-efficacy analysis of peginterferon alfa-2b plus ribavirin compared with peginterferon alfa-2a plus ribavirin for the treatment of chronic hepatitis C.

Malone DC, Tran TT, Poordad FF. Malone DC, et al. Among authors: poordad ff. J Manag Care Pharm. 2005 Oct;11(8):687-94. doi: 10.18553/jmcp.2005.11.8.687. J Manag Care Pharm. 2005. PMID: 16194133 Free PMC article.

7

Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase IIb and III studies.

Manns MP, Fried MW, Zeuzem S, Jacobson IM, Forns X, Poordad F, Peeters M, Fu M, Lenz O, Ouwerkerk-Mahadevan S, Jessner W, Scott JA, Kalmeijer R, De La Rosa G, Sinha R, Beumont-Mauviel M. Manns MP, et al. Among authors: poordad f. J Viral Hepat. 2015 Apr;22(4):366-75. doi: 10.1111/jvh.12346. Epub 2014 Nov 3. J Viral Hepat. 2015. PMID: 25363449

8

Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors.

Tran TT, Changsri C, Shackleton CR, Poordad FF, Nissen NN, Colquhoun S, Geller SA, Vierling JM, Martin P. Tran TT, et al. Among authors: poordad ff. J Gastroenterol Hepatol. 2006 Feb;21(2):381-3. doi: 10.1111/j.1440-1746.2005.03968.x. J Gastroenterol Hepatol. 2006. PMID: 16509862

9

Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents.

Poordad F, Dieterich D. Poordad F, et al. J Viral Hepat. 2012 Jul;19(7):449-64. doi: 10.1111/j.1365-2893.2012.01617.x. J Viral Hepat. 2012. PMID: 22676357 Review.

10

Imatinib (Gleevec)-induced hepatotoxicity.

Ayoub WS, Geller SA, Tran T, Martin P, Vierling JM, Poordad FF. Ayoub WS, et al. Among authors: poordad ff. J Clin Gastroenterol. 2005 Jan;39(1):75-7. J Clin Gastroenterol. 2005. PMID: 15599217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page